Valuation: Cannabis Bioscience International Holdings, Inc.

Market Cap 2.35M 2.06M 1.9M 1.77M 3.33M 221M 3.39M 22.77M 8.82M 109M 8.81M 8.61M 379M P/E 2024
-9.52x
P/E 2025 -11.8x
Enterprise Value 3.35M 2.94M 2.71M 2.53M 4.75M 316M 4.84M 32.49M 12.58M 156M 12.56M 12.29M 541M EV / Sales 2024
28.9x
EV / Sales 2025 25.6x
Free-Float
41.59%
Yield 2024 *
-
Yield 2025 -
04-16 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 CI
02-20 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 CI
23/10/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 CI
06/10/25 Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors CI
23/09/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 CI
22/09/25 Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
22/04/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025 CI
22/01/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 CI
06/01/25 Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products CI
27/12/24 Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding CI
27/11/24 Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024 CI
25/11/24 Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip CI
22/10/24 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2024 CI
1 day-23.33%
1 week-33.33%
1 month-33.33%
3 months-50.00%
6 months-66.67%
Current year-60.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0002
0
5 years 0
Extreme 0.0002
0.01
10 years 0
Extreme 0
0.27
Manager TitleAgeSince
Chief Executive Officer 70 19/12/2019
Treasurer 61 06/05/2024
Corporate Secretary 66 19/12/2019
Director TitleAgeSince
Director/Board Member 70 19/12/2019
Director/Board Member 66 19/12/2019
Director/Board Member 61 06/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-23.33%-33.33%-66.67%-66.67% 3.52M
+1.67%+9.28%-5.05%+1.40% 45.45B
+4.95%+9.31%+363.86%+598.16% 36.09B
+0.44%+11.12%+17.47%-12.91% 30.98B
-0.64%+1.92%+3.08%+53.58% 30.81B
+0.23%-0.29%+13.24%+21.10% 24.62B
+9.90%+13.32% - - 14.78B
+1.40%+12.99%+67.11%+132.76% 14.65B
+1.88%+8.59%+13.76%+20.68% 13.3B
+2.38%+5.69%+95.85%+97.63% 12.65B
Average -0.11%+3.72%+55.85%+93.97% 22.33B
Weighted average by Cap. +2.13%+6.77%+77.89%+128.88%

Financials

2024 2025
Net sales 249K 219K 201K 188K 353K 23.48M 360K 2.42M 936K 11.57M 934K 914K 40.22M 303K 266K 245K 229K 430K 28.59M 438K 2.94M 1.14M 14.09M 1.14M 1.11M 48.98M
Net income -651K -572K -527K -493K -924K -61.46M -941K -6.32M -2.45M -30.3M -2.45M -2.39M -105M -549K -482K -444K -415K -779K -51.79M -793K -5.33M -2.06M -25.53M -2.06M -2.02M -88.71M
Net Debt 939K 825K 760K 711K 1.33M 88.64M 1.36M 9.12M 3.53M 43.69M 3.53M 3.45M 152M 1M 879K 810K 757K 1.42M 94.4M 1.45M 9.71M 3.76M 46.53M 3.76M 3.67M 162M
Logo Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.
Employees
2
Date Price Change Volume
25/06/26 $0.000230 -23.33% 140,501,980
24/06/26 $0.000300 0.00% 100
23/06/26 $0.000300 0.00% 608,727
22/06/26 $0.000300 0.00% 22,000
18/06/26 $0.000300 0.00% 2,580,000
  1. Stock Market
  2. Stocks
  3. CBIH Stock